The RBM Case Management Working Group (CMWG) brings together a wide range of partners - including national malaria programmes, researchers, health workers, donors, pharmaceutical companies, and international agencies - to minimise duplication, improve coordination, and support more effective use of resources. The CMWG helps partners agree on practical approaches for the uptake and scale-up of proven malaria case management strategies and shares evidence-based best practices.

Universal access to prompt malaria diagnosis and effective treatment is a core element of the RBM strategy. This supports improved quality of care and ensures the rational use of antimalarials through coordinated, multi-disciplinary action. The CMWG addresses key challenges such as drug resistance, parasites with HRP2 deletions, and weak health systems by convening partners working across diagnostics, drug provision, treatment access, behavioural change, resistance mitigation, and impact measurement. It provides a forum to build consensus on strategies, develop expert task forces, identify research priorities, and collaborate with other RBM working groups.

In addition, the CMWG facilitates mutual learning and communication by accelerating information exchange, advising on resource allocation and capacity-strengthening needs, and advocating for increased attention and investment in malaria case management.